Inagene
Inagene Diagnostics Inc. is a Toronto-based private pharmacogenetic testing company that sells direct-to-consumer cheek-swab DNA kits predicting medication response across 200+ drugs, serving individual consumers, partner pharmacies, and healthcare providers across Canada and internationally.
- Company typePrivate
- Founded2018
- HeadquartersToronto, Canada
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Inagene does
Inagene Diagnostics Inc. is a Toronto-based, privately-held pharmacogenetic testing company that sells direct-to-consumer cheek-swab DNA tests designed to predict how an individual will respond to prescribed medications. Its core product portfolio includes Complete Health (covering 200+ medications across mental health, pain, cardiovascular, women's health, oncology, and neurology), Pain & Mental Health (100+ medications), Women's Health (80 medications), and Cardiovascular Health (49 medications), priced between $299 and $399 CAD. The company also offers a Nutrition & Fitness test via a strategic partnership with Nutrigenomix, plus a Complete Health + Nutrition bundle, and an annual subscription called the Inagene Advantage Membership ($125–$149/year) that delivers quarterly report updates as pharmacogenetic science evolves.
All samples are processed in Inagene's own CLIA-accredited laboratory using Agena MassARRAY molecular technology, with claimed >99.9% analytical accuracy and a 7-business-day turnaround. The company is ISO27001-certified and PIPEDA-compliant, and emphasizes that DNA is destroyed when no longer needed and customer data is never sold. The company serves three customer segments in parallel: individual consumers purchasing through the inagene.com storefront, healthcare providers (physicians, nurse practitioners, pharmacists, community clinics, and specialist practices) reached through a B2B sales channel, and partner pharmacies across Canada that resell kits and provide pharmacist-led consultations. The business model combines one-time kit revenue ($299–$399), recurring subscription revenue ($125–$149/year), and HCP-driven professional services revenue, with international shipping available beyond Canada and the US for an additional fee.
Inagene firmographics
Firmographics- Name
- Inagene
- Legal name
- Inagene Diagnostics Inc.
- Website
- https://inagene.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Inagene Diagnostics Inc. is a Toronto-based private pharmacogenetic testing company that sells direct-to-consumer cheek-swab DNA kits predicting medication response across 200+ drugs, serving individual consumers, partner pharmacies, and healthcare providers across Canada and internationally.
- Ownership category
- akta.pro rank
Inagene industry classification
Industry- Product category
- Pharmacogenetic Testing Services
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Health and Personal Care Retailers (456)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Pharmacogenomics (PGx) Decision Support (HLAAANAB)
- akta.pro secondary industries
- Home Diagnostic & Self-Test OTC Kits (HLAIADAO), Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where Inagene is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Inagene business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Genetic Test Kits: One-time purchase of pharmacogenetic test kits that provide personalized medication response reports. Prices range from $299 to $399 depending on test comprehensiveness. Includes free shipping in Canada and US.
- Inagene Advantage Membership: Annual subscription service providing quarterly report updates with new medications and refined recommendations as pharmacogenetic science evolves. Membership prices are $125/year for targeted tests ($299 kits) or $149/year for Complete Health. Includes complimentary re-swab when test is improved to analyze additional genes.
- Healthcare Provider Services: Services to healthcare providers including HCP portal accounts, test requisition forms, and promotional materials for partner pharmacies. Healthcare providers can order tests and access patient reports through the portal.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Pain & Mental Health Test - $299 |
| One time/ perpetual license | Pay-as-you-go | Women's Health Test - $299 |
| One time/ perpetual license | Pay-as-you-go | Cardiovascular Health Test - $299 |
| One time/ perpetual license | Pay-as-you-go | Complete Health Test - $399 |
| One time/ perpetual license | Pay-as-you-go | Nutrition & Fitness Test - $399 |
| One time/ perpetual license | Pay-as-you-go | Complete Health + Nutrition Bundle - $399 |
| Subscription | Annual | Advantage Membership (Targeted Tests) - $125/year |
| Subscription | Annual | Advantage Membership (Complete Health) - $149/year |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
Inagene product offering
Product offeringCore offering
Inagene Diagnostics Inc. sells at-home pharmacogenetic (PGx) test kits that analyze a customer's cheek-swab DNA sample at its CLIA-accredited Toronto laboratory to produce personalized reports predicting how an individual will respond to specific medications across pain, mental health, cardiovascular, women's health, oncology, neurology, and other therapeutic areas. The company also offers a nutrition and fitness genetic test via a partnership with Nutrigenomix, and an optional annual subscription (Inagene Advantage Membership) that delivers quarterly updates as pharmacogenetic science evolves.
Product overview
Inagene offers a portfolio of pharmacogenetic testing products delivered via cheek swab kits that analyze DNA to predict medication response. The core product lineup includes Complete Health (covering 200+ medications), Pain & Mental Health (100+ medications), Women's Health (80 medications), and Cardiovascular Health (49 medications), all available as standalone tests or bundled together. The company also partners with Nutrigenomix to offer a Nutrition & Fitness test covering genetic factors affecting diet and lifestyle. A Complete Health + Nutrition Bundle combines medication response and nutrition testing. An optional Inagene Advantage Membership subscription provides quarterly report updates as new pharmacogenetic research emerges. All products are processed through the company's CLIA-accredited laboratory in Toronto, Canada, with results delivered through a secure online portal.
Differentiator
Problem solved
Functional benefit
Brands
- Inagene Advantage Membership: Subscription service for pharmacogenetic testing customers that provides quarterly report updates reflecting new scientific discoveries and medication additions.
Products and services
- Complete Health Test
Quantifiable outcome
- Adverse drug reactions account for up to 30% of hospitalizations and are the #4 cause of death in North America
- +1 more outcomes
Companies that use Inagene
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Inagene technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Inagene partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NutrigenomixcoreInagene has partnered with Nutrigenomix to offer Nutrition and Fitness testing based on DNA. Nutrigenomix is described as the global leader in genetic testing for personalized nutrition with an award-winning panel of genetic tests. The partnership provides Inagene customers access to 70 genetic markers covering weight management, nutrient recommendations, heart health, food intolerances, eating habits, athletic performance, and more. Testing results are delivered as a separate report alongside the pharmacogenetic medication response report.
Scale indicators5 records
Recent moves1 record
Expansion highlights6 records
Inagene competitors and assessment
Company assessmentEmerging players
- SelfDecode: DTC DNA testing and wellness platform with PGx-adjacent reports. Comparable to Inagene on online-first DTC distribution and self-pay consumer audience.
- Nutrigenomix: Global leader in genetic testing for personalized nutrition and an existing Inagene partner. Comparable on nutrigenomic panel content, B2B2C distribution, and scientific positioning.
- Genome Medical: Telehealth-enabled clinical genetics and pharmacogenomics service. Comparable to Inagene on provider-mediated PGx interpretation and the broader push to integrate genetics into routine prescribing.
Broad incumbents
- 23andMe: Large DTC genetics platform with pharmacogenetic-related reports among broader health and ancestry offerings. Comparable on cheek-swab DTC mechanics and consumer brand, though PGx is not its primary focus.
Direct peers
- RxGenomix: Pharmacogenomics services company focused on clinical implementation with pharmacies and providers. Directly comparable to Inagene on PGx-as-a-service, pharmacy partnerships, and clinician education.
- Genomind: US-based pharmacogenetic testing company focused on mental health medication response (e.g., Genecept Assay). Directly comparable to Inagene's Pain & Mental Health test in product, target clinician, and DTC-plus-HCP model.
- Myriad Genetics (GeneSight): GeneSight by Myriad is the leading psychiatric PGx test in North America. Directly comparable to Inagene's Pain & Mental Health and broader panels in scope, HCP prescription motion, and insurance reimbursement strategy.
- Dynamic DNA Labs: DTC and clinician-focused PGx and nutrigenomics testing company. Comparable to Inagene on cheek-swab collection, online ordering, and panel-based medication-response reporting.
- YouScript (by Aranscia): PGx decision-support platform integrated into clinical workflows. Comparable to Inagene on PGx reporting, medication recommendations, and HCP-facing tools.
- Admera Health: CLIA-certified clinical PGx and molecular diagnostics lab offering pharmacogenomic panels to clinicians and consumers. Closely comparable to Inagene on lab operations, panel breadth, and HCP/DTC dual GTM.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Inagene social profiles
Digital presenceInagene compliance and trust
Trust signalCompliance3 records
Inagene financial estimates
Financial estimateRevenue estimate
Valuation estimate
Inagene leadership team
Management profileNumber of profiles
Inagene funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Inagene M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Inagene
What does Inagene do?
Inagene Diagnostics Inc. sells at-home pharmacogenetic (PGx) test kits that analyze a customer's cheek-swab DNA sample at its CLIA-accredited Toronto laboratory to produce personalized reports predicting how an individual will respond to specific medications across pain, mental health, cardiovascular, women's health, oncology, neurology, and other therapeutic areas. The company also offers a nutrition and fitness genetic test via a partnership with Nutrigenomix, and an optional annual subscription (Inagene Advantage Membership) that delivers quarterly updates as pharmacogenetic science evolves.
Is Inagene a public or private company?
Inagene is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Inagene founded?
Inagene was founded in 2018. It employs 1 to 10 people.
Where is Inagene based?
Inagene is headquartered in Toronto, Canada, in the North America region.
How does Inagene make money?
Three revenue lines are on record. Genetic Test Kits are the primary driver. The others are inagene Advantage Membership and healthcare Provider Services.
Who are Inagene's main competitors?
Emerging players on record are SelfDecode, Nutrigenomix and Genome Medical. 23andMe is listed as a broad incumbent. Direct peers are RxGenomix, Genomind, Myriad Genetics (GeneSight), Dynamic DNA Labs, YouScript (by Aranscia) and Admera Health.
Does Inagene have an API?
No public API is recorded for Inagene.
What industry is Inagene in?
Inagene's product category is Pharmacogenetic Testing Services. Its primary akta.pro industry code is HLAAANAB, Pharmacogenomics (PGx) Decision Support, with a secondary code of HLAIADAO, Home Diagnostic & Self-Test OTC Kits. Its NAICS code is 325413 and its SIC code is 2835.